Glyburide Tablet
Product Images NDC 71209-009

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 71209-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-label-1000s-count-1-25mg.jpg (Container Label 1000s Count 1 25mg)

This appears to be a label for a medication, specifically GlyBURIDE Tablets, USP. The label includes dosage instructions, storage information, and safety warnings. It is manufactured by Cadila Pharmaceuticals Ltd in India.*

FDA Label Image

Container-label-1000s-count-2-5mg.jpg (Container Label 1000s Count 2 5mg)

This appears to be a product description for GlyBURIDE tablets, USP manufactured by Cadila Pharmaceuticals LTD in India. The tablets are dispensed in 25 g quantities and have a controlled room temperature range between 15-30 degrees Celsius. The tablets should be kept away from children and manufactured according to the standards of the US Pharmacopeia.*

FDA Label Image

Container-label-1000s-count-5mg.jpg (Container Label 1000s Count 5mg)

This appears to be a description of a medication called GlyBURIDE in tablet form, with a strength of 5mg per tablet. The recommended dosage may vary based on factors such as age and medical condition. There are also warnings to keep the medication out of reach of children. The manufacturer is listed as CADILA PHARMACEUTICALS LTD, located in Gujarat, India. Additionally, there is a reference to a medication number and a lot number.*

FDA Label Image

Container-label-100s-count-1-25mg.jpg (Container Label 100s Count 1 25mg)

FDA Label Image

Container-label-100s-count-2-5mg.jpg (Container Label 100s Count 2 5mg)

FDA Label Image

Container-label-100s-count-5mg.jpg (Container Label 100s Count 5mg)

FDA Label Image

Container Label 500s Count 2 5mg

Each tablet contains 2.5 mg glyburide, and it is recommended to store it at 20-25°C with directions provided in accompanying literature. The tablet should be dispensed in a tight, light-resistant container with child-resistant closure. It is crucial to keep the medication out of the reach of children. The manufacturer is Cadila Pharmaceuticals Ltd, located in Gujarat State, India, and their manufacturing license number is G/1500. The tablets are marked with Noc 71208-010-10 and the name "GlyBURIDE". Actual size specifications and label color information are also provided.*

FDA Label Image

Container Label 500s Count 5mg

Each tablet of GlyBURIDE contains 5 g of USP. The recommended storage temperature is between 20°C to 25°C (66°F to 77°F) with limited excursions allowed. Keep the medication in a secure and light-resistant container with a child-resistant closure. It is essential to keep all medications out of children's reach. The manufacturer is Cadila Pharmaceuticals Ltd, with Mfg. Lic. No.: G/1500, located in Gujarat State, India. The tablet is used as a diabetes medication, and the usual dosage can be found in the accompanying literature. The label dimensions are 120 x 45 mm.*

FDA Label Image

Glyburide-fig-1 (Glyburide Fig 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.